France’s competition authority is investigating Novartis AG and Roche Holding AG for possible collusion to prevent the use of Roche’s Avastin cancer drug as a treatment for an eye disease, the health-care ministry said.
The U.S. Supreme Court deferred a decision on whether to hear an appeal by Teva Pharmaceutical Industries Ltd. that aims to delay generic competition to its top-selling Copaxone multiple-sclerosis drug.
Apotex Inc. must face a Roche Holding AG lawsuit claiming its generic version of Valcyte, which treats a virus that afflicts transplant patients and people with AIDS, infringes a Roche patent that expires in 2015.
Regeneron Pharmaceuticals Inc. and Sanofi and must assess how their experimental cholesterol drug affects brain function after U.S. regulators learned of adverse events associated with this new class of medicines.
Italy’s antitrust regulator fined Novartis AG and Roche Holding AG 182.5 million euros ($251 million) for allegedly colluding to prevent the use of Roche’s Avastin cancer drug as a treatment for an eye disease.
Roche Holding AG’s new chairman signaled today he’ll follow his predecessor’s tight-fisted approach toward acquisitions even now that the drugmaker has paid down much of the debt from its last big deal.
European stocks plunged the most in more than a month, retreating after reaching a six-year high last week, as investor concern increased that the escalating tension in Ukraine will hurt corporate earnings.
Aiming deep inside the brain, drugmakers are testing medicines that may improve learning in people with Down syndrome, an advance unimaginable 50 years ago when many children with the genetic condition were considered hopelessly disabled.